SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001213900-22-017660
Filing Date
2022-04-04
Accepted
2022-04-04 07:30:24
Documents
2
Group Members
YAT-GAI AU

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 3 TO SCHEDULE 13D ea157937-13da3regen_regen.htm SC 13D/A 65472
2 JOINT FILING AGREEMENT, DATED APRIL 4, 2022 ea157937ex99-1_regen.htm EX-99.1 5725
  Complete submission text file 0001213900-22-017660.txt   72859
Mailing Address 11/F FIRST COMMERCIAL BUILDING 33-35 LEIGHTON ROAD, CAUSEWAY BAY HONG KONG K3 999077
Business Address 11/F FIRST COMMERCIAL BUILDING 33-35 LEIGHTON ROAD, CAUSEWAY BAY HONG KONG K3 999077 852 2155 0823
Regencell Bioscience Holdings Ltd (Subject) CIK: 0001829667 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9
Type: SC 13D/A | Act: 34 | File No.: 005-92718 | Film No.: 22800376
SIC: 2833 Medicinal Chemicals & Botanical Products

Mailing Address 11/F FIRST COMMERCIAL BUILDING 33-35 LEIGHTON ROAD, CAUSEWAY BAY HONG KONG K3 999077
Business Address 11/F FIRST COMMERCIAL BUILDING 33-35 LEIGHTON ROAD, CAUSEWAY BAY HONG KONG K3 999077 852 2155 0823
Regencell (BVI) Ltd (Filed by) CIK: 0001874958 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8
Type: SC 13D/A